NEW YORK--Judah Folkman, MD, who first theorized that tumors form
and metastasize by means of angiogenesis, is the winner of the
18th annual Bristol-Myers Squibb Award for Distinguished Achievement
in Cancer Research.
In 1971, Dr. Folkman reported the isolation of the first angiogenic
factor, a substance that induces blood vessel growth. In 1984,
he and his colleagues Yuen Shing and Michael Klagsbrun purified
the first tumor-derived angiogenic factor, and Dr. Folkman later
discovered the first angiogenesis inhibitor.
Dr. Folkman is Julia Dyckman Andrus Professor of Pediatric Surgery,
Harvard Medical School, and director of the Surgical Research
Laboratory, Children's Hospital, Boston.
The company also announced the recipients of the 1995 Bristol-Myers
Squibb Unrestricted Cancer Research Grants--Indiana University
Cancer Center and the National Cancer Institute, Milan.